UALCAN (v1.0)2 is an interactive internet-based platform for carrying out detailed analyses of TCGA genetic expression data and utilizes TCGA 3rd level of clinical and RNA-seq information derived from 31 types of cancer (Chandrashekar et al., 2017). We used UALCAN for quantification of a target gene(s)’ relative expression across different grades of tumors and stages of cancer, across healthy tissue and tumor tissue samples, and several other types of clinicopathological characteristics (at October 2020).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.